About Innovative Eyewear, Inc.
https://www.lucyd.coInnovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free.
CEO
Harrison Reed Gross
Compensation Summary
(Year 2024)
Salary $167,385
Stock Awards $351,936
All Other Compensation $8,089
Total Compensation $527,410
Industry Medical - Instruments & Supplies
Sector Healthcare
Went public August 15, 2022
Method of going public IPO
Full time employees 11
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
No price data available
Market Cap $320476
52w High $0.49
52w Low $0.02
P/E 0
Volume 32.98K
Outstanding Shares 5.35M
About Innovative Eyewear, Inc.
https://www.lucyd.coInnovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $668.13K ▲ | $2.17M ▲ | $-1.84M ▲ | -274.84% ▲ | $-0.38 ▲ | $-1.89M ▲ |
| Q2-2025 | $579.23K ▲ | $2.16M ▲ | $-2.11M ▼ | -363.6% ▲ | $-0.66 ▲ | $-2.13M ▼ |
| Q1-2025 | $454.5K ▼ | $2.12M ▼ | $-1.78M ▲ | -391.35% ▼ | $-1.19K ▼ | $-1.87M ▲ |
| Q4-2024 | $690.69K ▲ | $2.27M ▲ | $-2.13M ▼ | -307.83% ▲ | $-0.87 ▲ | $-2.09M ▼ |
| Q3-2024 | $253.6K | $1.82M | $-1.72M | -678.5% | $-0.99 | $-1.69M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $6.7B ▲ | $11.18B ▲ | $925M ▲ | $10.25B ▲ |
| Q2-2025 | $8.91M ▲ | $11.94M ▲ | $658.52K ▲ | $11.28M ▲ |
| Q1-2025 | $5.26M ▼ | $7.94M ▼ | $447.24K ▼ | $7.49M ▼ |
| Q4-2024 | $7.52M ▼ | $9.84M ▼ | $743.17K ▲ | $9.1M ▼ |
| Q3-2024 | $9.44M | $11.6M | $665.91K | $10.93M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.84M ▲ | $-1.5M ▲ | $-14.84K ▲ | $584.4K ▼ | $-927.87K ▼ | $-1.51M ▲ |
| Q2-2025 | $-2.11M ▼ | $-2.12M ▲ | $-1.27M ▼ | $5.76M ▲ | $2.37M ▼ | $-2.12M ▲ |
| Q1-2025 | $-1.78M ▲ | $-2.31M ▼ | $4.94M ▲ | $0 ▼ | $2.63M ▲ | $-2.37M ▼ |
| Q4-2024 | $-2.13M ▼ | $-1.94M ▼ | $-61.42K ▲ | $89.85K ▼ | $-1.91M ▼ | $-1.97M ▼ |
| Q3-2024 | $-1.72M | $-1.4M | $-4.99M | $5.03M | $-1.35M | $-1.49M |
CEO
Harrison Reed Gross
Compensation Summary
(Year 2024)
Salary $167,385
Stock Awards $351,936
All Other Compensation $8,089
Total Compensation $527,410
Industry Medical - Instruments & Supplies
Sector Healthcare
Went public August 15, 2022
Method of going public IPO
Full time employees 11
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0